Nav: Home

Academics call for Parliament to tackle the privatization of NHS

March 24, 2017

A bill to prevent the privatisation of NHS services and to reinstate the NHS in England, supported and written by Newcastle University academics, is scheduled to be debated today.

On Friday 24th March, the NHS Reinstatement Bill will be presented in the House of Commons by Margaret Greenwood, Labour MP for Wirral West.

It is the result of a body of work by Newcastle University academic Professor Alyson Pollock and colleague, barrister Peter Roderick.

Professor Pollock, the newly-appointed Director of the Institute of Health and Society, Newcastle University, said: "The NHS has been one of the UK's greatest achievements and for almost 70 years it has provided a cost effective, universal health service. Yet this has been eroded.

"I believe the Health and Social Care Act 2012, forced a commercialised model on the NHS in England as the first thing it did was remove the duty on the Health Secretary to provide services throughout England. In effect this makes commercial tendering virtually compulsory.

"The result is billions of pounds of NHS money and thousands of health services put out to commercial tendering, removing scarce resources from the system and putting them into the private sector instead.

"The aim of today's Bill is to force the issue into the open, and allow debate on what I consider as a momentous failing to society."

The Bill proposes that the NHS should be restored as a public service by reversing marketization in the NHS, by abolishing the purchaser-provider split ending contracting and re-establishing public bodies and public services accountable to local communities.

The academic team believe this is necessary to stop the dismantling of the NHS under the Health and Social Care Act 2012.

Allyson Pollock was professor of public health research and policy at Queen Mary University of London, and set up and directed the Centre for International Public Health Policy at the University of Edinburgh before moving to Newcastle.

Her research at Newcastle University will focus on health inequalities, the privatisation and marketization of health services, pharmaceuticals and clinical trials and will build on her well-respected work on sports injury, in particular head injuries.

The Bill was co-written with the help of Peter Roderick, Principal Research Associate within the Institute of Health and Society.

He said: "In writing this bill, we are reinstating the founding principles which made the NHS. These have been eroded and they will not be restored unless Parliament passes a law to do so."

MP Margaret Greenwood took up the Bill because of growing public concern about the state of the NHS and she is calling on people concerned about the NHS to write to their MP to ask them to support the Bill.

Another key supporter of the Bill is MP for North Tyneside, Mary Glindon.
-end-


Newcastle University

Related Clinical Trials Articles:

Review evaluates how AI could boost the success of clinical trials
In a review publishing July 17, 2019 in the journal Trends in Pharmacological Sciences, researchers examined how artificial intelligence (AI) could affect drug development in the coming decade.
Kidney patients are neglected in clinical trials
The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients.
Clinical trials beginning for possible preeclampsia treatment
For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia -- a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies.
Underenrollment in clinical trials: Patients not the problem
The authors of the study published this month in the Journal of Clinical Oncology investigated why many cancer clinical trials fail to enroll enough patients.
When designing clinical trials for huntington's disease, first ask the experts
Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments.
More Clinical Trials News and Clinical Trials Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...